Insights in Psychopharmacology: 2022

4,413
Total downloads
14k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 04 Jan 2023

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study

Gregory Mattingly
Elizabeth Brunner
Lambros Chrones
Debra F. Lawrence
Kenneth Simonsen
Hongye Ren

doi 10.3389/fpsyt.2022.977560

2,616 views
6 citations

REVIEW

Published on 10 Nov 2022

Biology of cyclooxygenase-2: An application in depression therapeutics

Ying He
Yuanshan Han
Xiaolin Liao
Manshu Zou
Yuhong Wang

doi 10.3389/fpsyt.2022.1037588

3,486 views
16 citations

CASE REPORT

Published on 06 Sep 2022

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist

Satoko Sumi
Takahiko Nagamine
Koji Sumi
Reona Aijima
Kyoko Oka
Akira Toyofuku

doi 10.3389/fpsyt.2022.976387

1,914 views
8 citations

ORIGINAL RESEARCH

Published on 21 Jun 2022

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia

Huimei An
Hongzhen Fan
Yajun Yun
Song Chen
Siyuan Qi
Botao Ma
Jing Shi
Zhiren Wang
Fude Yang

doi 10.3389/fpsyt.2022.930457

1,620 views
5 citations

CASE REPORT

Published on 27 Apr 2022

Case Report: Long-Acting Oral Cariprazine

Emanuela Dyrmishi
Marco De Pieri
Marco Ferrari
Rafael Traber
Matteo Preve
Luca De Peri
Emilio Bolla

doi 10.3389/fpsyt.2022.876003

4,235 views
5 citations

Share on

Frontiers in Psychiatry

Frontiers in Psychiatry

Psychopharmacology

Impact

14kTopic views
10kArticle views
4,413Article downloads